# Bionano Genomics, Inc.: Form DEF 14A, filed Dec 5, 2024

- Company: [Bionano Genomics, Inc.](/companies/bngo.md) (CIK 1411690)
- Form: DEF 14A
- Filed: 2024-12-05
- Accepted by EDGAR: Dec 5, 2024, 17:00 ET
- Period: 2025-01-15
- Accession: 0001140361-24-048499
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1411690/000114036124048499/ny20038781x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411690/000114036124048499/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411690/000114036124048499/ny20038781x2_def14a.htm

Filed Dec 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-048499. Last ingested by Listed: Nov 6, 2026, 10:56 ET. No prices; not investment advice.